Pharmaceutical company pays $54 million in settlement for FCA violation
On January 6, Teva Pharmaceuticals agreed to pay $54 million to settle allegations that the company violated the False Claims Act and the Anti-Kickback Statute by providing unlawful compensation to physician speakers. The allegations were based on whistleblowers’ claims made in 2013.
This document is only available to members. Please log in or become a member.